KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EPS (Weighted Average and Diluted) (2019 - 2025)

Precigen (PGEN) has disclosed EPS (Weighted Average and Diluted) for 11 consecutive years, with -$1.06 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 1077.78% to -$1.06 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.38, a 150.91% decrease, with the full-year FY2024 number at -$0.47, down 20.51% from a year prior.
  • EPS (Weighted Average and Diluted) was -$1.06 for Q3 2025 at Precigen, down from -$0.09 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.04 in Q3 2022 to a low of -$1.06 in Q3 2025.
  • A 5-year average of -$0.16 and a median of -$0.1 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 73.33% in 2022, then tumbled 1077.78% in 2025.
  • Precigen's EPS (Weighted Average and Diluted) stood at -$0.11 in 2021, then fell by 18.18% to -$0.13 in 2022, then increased by 0.0% to -$0.13 in 2023, then soared by 61.54% to -$0.05 in 2024, then plummeted by 2020.0% to -$1.06 in 2025.
  • Per Business Quant, the three most recent readings for PGEN's EPS (Weighted Average and Diluted) are -$1.06 (Q3 2025), -$0.09 (Q2 2025), and -$0.18 (Q1 2025).